Bristol-Myers maps $250M manufacturing expansion to support growing R&D effort

John Carroll Score another big win for Greater Boston's growing biotech hub. Bristol-Myers Squibb ($ BMY)–which startled the industry earlier this week with its plans to ...

Sanofi at vanguard with new process for antimalarial drugs

Eric Palmer French drugmaker Sanofi ($ SNY) said today it is gearing up to produce tons of artemisinin, the key ingredient for antimalarial treatments. Artemisinin usually comes ...

Syros Pharma snags $30M funding deal to target master switches of cancer genes

Ryan McBride With licenses to breaking discoveries from labs affiliated with MIT and Harvard, Syros Pharmaceuticals has raised $ 30 million in a Series A round of financing from top ...

Pfizer Ventures backs effort to amp up orphan-drug development

Tracy Staton David Mott, ex-CEO of MedImmune and a high-profile biotech partner at New Enterprise Associates, has led the way toward an orphan drug accelerator also backed by Pfizer ...

UPDATED: GlaxoSmithKline measures 36-meter leap over placebo in Duchenne walking test

John Carroll GlaxoSmithKline investigator John Kraus reviewed the long-awaited mid-stage results for its Duchenne muscular dystrophy drug drisapersen this afternoon, revealing that ...

Eli Lilly to lay off hundreds in sales as Cymbalta nears edge of patent cliff

Here is a business reality that hundreds of Eli Lilly ($ LLY) sales employees are going to have to align themselves with quite soon: They are about to lose their jobs. With its best-selling ...
Page 17 of 17« First...10...1314151617
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS